Stocks

Neonode (NEON) Stock Continues Meteoric Rise on Strategic Pivot and Promising Patent Lawsuit vs. Samsung and Apple

Neonode (NASDAQ: NEON), a technology company specializing in optical sensing solutions, has made significant strides this year, marked by a…

Read More »

Therma Bright Adds Experienced Pharma and Medical Device Industry Veteran to Advisory Board

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in advanced diagnostic and medical device technologies,…

Read More »

Trump Media (DJT) Stock Faces Sharp Decline as Lock-Up Date Looms

Trump Media & Technology Group (NASDAQ: DJT), the parent company of Truth Social, is grappling with significant stock market volatility…

Read More »

Therma Bright (THRM) Stock Surges Following Key Medicare and Medicaid Win in $1B DVT Market

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a medical device manufacturer, has made significant strides in the healthcare sector…

Read More »

Temu Parent PDD Holdings Stock Plummets 28% Despite Strong Q2 Earnings Growth

PDD Holdings (NASDAQ: PDD) saw its stock decline 28% today, despite the parent company of popular e-commerce platforms Temu and…

Read More »

Peloton Interactive (PTON) Stock Explodes 35% on Surprise Q4 Earnings Beat

Peloton Interactive (NASDAQ: PTON), the connected fitness giant, has delivered its first year-over-year sales increase in nine quarters, marking a…

Read More »

Therma Bright Adds New U.S. Nationwide Venowave Distribution Partner

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in a wide range of leading-edge, proprietary…

Read More »

All Systems Go: AST SpaceMobile (ASTS) Stock Throttles Up En Route to the Stars

AST SpaceMobile (NASDAQ: ASTS) stock continued its meteoric ascent today, as the trailblazing telecommunications company moves closer to potentially the most…

Read More »

Palo Alto Networks (PANW) Soars on Strong Q4 Earnings, 9 Analysts Raise Price Target on Stock

Palo Alto Networks (NASDAQ: PANW) saw a significant rise in its stock following the release of its fourth-quarter financial results,…

Read More »

Tempest Therapeutics (TPST) Stock Jumps 83% on FDA Phase 3 Trial News

Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as…

Read More »
Back to top button